Former FDA Chief Counsel Elizabeth Dickinson Hailed For Her Expertise, Warmth and Mentorship
The Pink Sheet - September 27, 2022 In an article [...]
FDA User Fee Programs Reauthorized: FDA’s CBER Is A Clear Winner
Pharmaceutical Online/Cell & Gene/Bioprocess Online – October 6, 2022 PDUFA [...]
Catalyst will be participating in the Alliance for Regenerative Medicine Cell & Gene Meeting on the Mesa in Carlsbad, CA from October 11-13, 2022.
Shoot us an email and let’s catch up.
FDAnews Webinar: On Challenges Facing the New FDA Commissioner
During her panel for FDAnews, Nancy Myers highlighted impending challenges [...]
Marks Took On FDA Vaccine Leadership Position What Happens Now?
Outsourced PharmaOnline / PharmaceutialOnline — November, 1 2021 Nancy Bradish [...]
Accelerated Approval Standards: Application to Gene Therapy
At the ASGCT Policy Summit 2021, Nancy Bradish Myers shared [...]
Ruling Blocks Okla. MCO Program, But Fight May Not Be Over
AISHealth.com — June 25, 2021 Jeff Myers, Catalyst’s Senior Vice [...]
Not A Time For Novices: FDA Needs A Leader With Deep Agency Roots And Expertise
Clinical Leader Online – May 5, 2021 Nancy Bradish Myers [...]
Wall Street Sees Woodcock Commissionership As Positive for Aducanumab, But Eyes Should Be On Cavazzoni
Pink Sheet: Informa Pharma Intelligence – January 29, 2021 Nancy [...]
Woodcock Faces Maze Of Rules To Become Commissioner Nominee
Pink Sheet: Informa Pharma Intelligence – January 21, 2021 Nancy [...]